Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bicarbonate Ringer's solution is a balanced crystalloid intravenous fluid designed for fluid resuscitation and the maintenance of electrolyte and acid-base balance. Unlike traditional crystalloids such as 0.9% normal saline, which can lead to hyperchloremic metabolic acidosis, or lactated Ringer's solution, which requires hepatic metabolism of lactate to generate bicarbonate, this solution contains sodium bicarbonate as a direct buffering agent. This physiological composition is intended to support renal perfusion and reduce the incidence of acute kidney injury (AKI) and systemic inflammation. It is currently being evaluated in clinical trials, such as those led by Peking Union Medical College Hospital, for the initial resuscitation of patients with severe acute pancreatitis to improve 28-day mortality and renal outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bicarbonate Ringer's solution.